4 |
PREMIUM INSIGHTS ................................................................................................................. 32 |
|||
• 4.1 |
GLOBAL HUMAN INSULIN MARKET ( 2015 – 2020 ).......................................................................................................... 32 |
|||
• 4.2 |
GLOBAL HUMAN INSULIN DRUGS MARKET SIZE , BY TYPE ( 2015 )............................................................................... 33 |
|||
• 4.3 |
GLOBAL HUMAN INSULIN DELIVERY DEVICES MARKET SIZE , BY TYPE ( 2015-2020 ).................................................. 34 |
|||
• 4.4 |
GLOBAL HUMAN INSULIN DRUGS MARKET , BY BRAND ( 2015 VS . 2020 )..................................................................... 34 |
|||
• 4.5 |
GLOBAL HUMAN INSULIN PRODUCTS MARKET SIZE , BY COUNTRY ( 2015-2020 )....................................................... 35 |
|||
5 |
MARKET OVERVIEW .................................................................................................................. 36 |
|||
• 5.1 |
INTRODUCTION ............................................................................................................................................................... 37 |
|||
• 5.2 |
MARKET SEGMENTATION ................................................................................................................................................ 37 |
|||
• 5.3 |
MARKET EVOLUTION ....................................................................................................................................................... 38 |
|||
• 5.4 |
MARKET DYNAMICS ........................................................................................................................................................ 39 |
|||
• 5.4.1 |
KEY MARKET DRIVERS .................................................................................................................................. 40 |
|||
• 5.4.1.1 |
GROWTH IN THE NUMBER OF DIABETIC PATIENTS ................................................................ 40 |
|||
• 5.4.1.2 |
RISING MARKET DEMAND FOR HUMAN INSULIN ANALOGS ................................................. 41 |
|||
• 5.4.1.3 |
TECHNOLOGICAL ADVANCEMENTS IN HUMAN INSULIN DELIVERY DEVICES ...................... 42 |
|||
• 5.4.1.4 |
FAVORABLE MEDICAL REIMBURSEMENT SCENARIO IN DEVELOPED COUNTRIES ............... 43 |
|||
• 5.4.2 |
KEY MARKET RESTRAINTS ............................................................................................................................ 43 |
|||
• 5.4.2.1 |
STRINGENT REGULATORY REQUIREMENTS FOR PRODUCT APPROVAL ................................ 43 |
|||
• 5.4.3 |
KEY MARKET OPPORTUNITIES ..................................................................................................................... 44 |
|||
• 5.4.3.1 |
EXPANSION OF HEALTHCARE INFRASTRUCTURE ACROSS EMERGING MARKETS ............... 44 |
|||
• 5.4.3.2 |
EXPECTED PATENT EXPIRY OF KEY HUMAN INSULIN DRUGS ............................................... 45 |
|||
• 5.4.4 |
KEY MARKET CHALLENGE ............................................................................................................................ 45 |
|||
• 5.4.4.1 |
HIGH PRODUCT MANUFACTURING COSTS ............................................................................ 45 |
|||